NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco ...Middle East

The benefits of ketamine are clear, but so are the risks Ketamine has now demonstrated clear superiority to placebo and non-inferiority to electroshock therapy in randomized trials encompassing more than 1,000 patients NRx to file a New Drug Application for ketamine to treat suicidal...

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco )

Also on site :

• Lou Christie, “Lightnin’ Strikes” and “Rhapsody in the Rain” Singer, Dies at 82
• Bruce Springsteen Hints at New Music and Reveals Upcoming Box Set
• Detained Afghan’s legal entry into U.S. was ‘improvident,’ government argues